Zobrazeno 1 - 10
of 213
pro vyhledávání: '"HuscFv"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sawatpiboon N; Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Chulanetra M; Center of Research Excellence in Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Chaicumpa W; Center of Research Excellence in Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Duang Sa-Ard S; Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Kasetsinsombat K; Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Wongkajornsilp A; Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Publikováno v:
Asian Pacific journal of allergy and immunology [Asian Pac J Allergy Immunol] 2024 Nov 17. Date of Electronic Publication: 2024 Nov 17.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mungchan, Pennapa1 (AUTHOR), Glab-ampai, Kittirat2 (AUTHOR), Chruewkamlow, Nuttapol3 (AUTHOR), Trakarnsanga, Kongtana1 (AUTHOR), Srisawat, Chatchawan1,4 (AUTHOR), Nguyen, Kytai T.5 (AUTHOR), Chaicumpa, Wanpen2 (AUTHOR), Punnakitikashem, Primana1,4 (AUTHOR) primana.pun@mahidol.ac.th
Publikováno v:
Molecules. Dec2022, Vol. 27 Issue 23, p8144. 17p.
Autor:
Yousefi, Mohammadreza1,2, Farajnia, Safar2 farajnias@tbzmed.ac.ir, Mokhtarzadeh, Ahad1,3, Akbari, Bahman4, Khosroshahi, Shiva Ahdi5, Mamipour, Mina1, Dariushnejad, Hassan6, Ahmadzadeh, Vahideh5
Publikováno v:
Avicenna Journal of Medical Biotechnology. 2018, Vol. 10 Issue 3, p141-146. 6p. 4 Diagrams, 2 Charts.
Autor:
Safar Farajnia, Shiva Ahdi Khosroshahi, Dianoush Falahatgar, Nosratollah Zarghami, Hadi Farajnia, Bahman Akbari, Asghar Tanomand
Publikováno v:
Iranian Journal of Biotechnology
Background: Epidermal growth factor receptor (EGFR) plays an important role in the progression and tumorigenesis of the various cancers. In this regards, anti-EGFR antibodies are valuable approved therapeutics for the EGFR over-expressing cancers. Ho
Autor:
Kantaphon Glab-ampai, Kodchakorn Mahasongkram, Monrat Chulanetra, Thanatsaran Saenlom, Kanyarat Thueng-in, Nitat Sookrung, Wanpen Chaicumpa
Publikováno v:
Microbial Cell Factories, Vol 22, Iss 1, Pp 1-16 (2023)
Abstract Background RNA-dependent RNA polymerase (RdRp) is a good target of anti-RNA virus agents; not only it is pivotal for the RNA virus replication cycle and highly conserved among RNA viruses across different families, but also lacks human homol
Externí odkaz:
https://doaj.org/article/fc6844ecb36843f7a73adc0b82262308
Autor:
Atefeh, Nazari, Safar, Farajnia, Seber, Zahri, Nazanin, Bagherlou, Asghar, Tanoumand, Leila, Rahbarnia
Publikováno v:
Iranian Journal of Biotechnology
Background: Overexpression of EGFR is associated with carcinogenesis in more than 70% of head and neck cancers. Anti-EGFR monoclonal antibodies bind to the extracellular domain of EGFR and block the EGFR downstream signaling pathway, which results in
Autor:
Sun, He1,2 (AUTHOR), Wu, Guangmou2 (AUTHOR), Zhang, Jiyuan3 (AUTHOR), Wang, Yu1,2 (AUTHOR), Qiu, Yue1,2 (AUTHOR), Man, Hongyang1,2 (AUTHOR), Zhang, Guoli2 (AUTHOR), Li, Zehong1 (AUTHOR), Yue, Yuhuan2 (AUTHOR) yhyue2013@163.com, Tian, Yuan2 (AUTHOR) yhyue2013@163.com
Publikováno v:
PLoS ONE. 3/31/2022, Vol. 17 Issue 3, p1-13. 13p.